Our FacilityTotal Manufacturing Area - 350,000 sq.ft.
Block-I (General Manufacturing)
The general block is equipped with a fully integrated line that consists of washing, drying, de-pyrogenation, filling, stoppering, and labeling with an automated visual inspection system and a serialization machine. The sterile manufacturing area and primary packaging area are class A as per the classification norms.
Liposomal Injections
Infusion Bags
Sterile Liquid Fill
Liquid Orals
Lyophilized Vials
Block-II (Potent Manufacturing)
Innoxel is set up to supply broad cytotoxic and potent drug production services. The highly sensitive and complex nature of manufacturing these compounds means only world-class facilities and experienced staff can be entrusted with their care.
Multi-vesicular Liposomes
Liquid Orals
Pre-Filled Syringes
Sterile Liquid Fill
Lyophilized Vials
The facility has also been designed to support the scale-up and commercial supply of:
- Liposomal & Lyophilized Injectable Formulations
- Complex Injectable Formulations
- Pre-filled Syringe (Long Acting) Formulations
- IR/XR Liquid Formulations
- Dual-chamber Infusion Bags
Innoxel’s one-of-a-kind manufacturing operations are augmented with enhanced infrastructure that includes:
- The science and the provisions for SKIDs for liposomal injectable and XR liquid products
- Highest ISO Standard compliant Advanced Barrier Technology - Isolators for Oncology Block and cRABS for General Block
- Quality Management System that is 21CFR Part 11 compliant
- BMS and EMS systems for environmental control and monitoring, along with online NVPC and VPC monitoring
- Automated CIP and SIP with a closed transfer system
- Automated IPC with a non-destructive in-process test
- Double-stage RO with ozonization and an advanced water generation and purification system.